Novel Drug Mechanisms Enter Alzheimer’s Treatment Pipeline
Yes, novel drug mechanisms are actively entering the Alzheimer's treatment pipeline, with 182 clinical trials and 138 novel drugs currently in development...
Category Diet
Immune Cell Engineering Opens New Front in Alzheimer’s Treatment
Immune cell engineering is opening a fundamentally new approach to Alzheimer's disease—one that goes beyond clearing plaques to actively reprogram the...
Long-Term Safety Data Released for Major Alzheimer’s Treatment
Recent data presented at the AD/PD 2026 conference in Copenhagen reveals that patients treated with LEQEMBI (lecanemab), an FDA-approved Alzheimer's...
Health Systems Collaborate on Cutting-Edge Alzheimer’s Treatments
Health systems across the country are joining forces through coordinated care networks, shared research initiatives, and collaborative infrastructure to...
Sorority Partners With National Organization to Address Brain Health Disparities
The Alzheimer's Association has partnered with Sigma Gamma Rho Sorority, Inc., one of the largest historically Black sororities, to directly address...
Alzheimer’s Treatment Registry Provides Real-World Patient Data
Alzheimer's treatment registries are transforming how we understand which therapies actually work in real patients—not just in controlled clinical trials.
Researchers Propose Fundamental Shift in Alzheimer’s Treatment Strategy
The fundamental shift in Alzheimer's treatment represents a pivotal departure from decades of single-target drug approaches.
Alzheimer’s Patients on Leqembi Show Long-Term Treatment Benefits
Yes, patients with Alzheimer's disease who receive long-term treatment with Leqembi (lecanemab) demonstrate measurable benefits in slowing cognitive...
Patient Data Shows Strong Adherence to Approved Alzheimer’s Treatment
Recent patient data confirms what researchers hoped: people are staying on approved Alzheimer's treatments at meaningful rates, and real-world...
Protein Complex Discovery Opens New Avenue for Alzheimer’s Treatment
Recent discoveries of toxic protein complexes in the brain have revealed new mechanisms by which Alzheimer's disease damages nerve cells—and, more...